Net Benefit of Anticoagulation in Subclinical Device-Detected Atrial Fibrillation.

JAMA Netw Open · 2025 · PMC12048845 · PMID 40314955

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

showed a trendno p-value reported

Additionally, a substudy of the ARTESiA trial showed a trend toward better stroke prevention with NOACs in patients with higher stroke risk scores. 9 However, this trend was not statistically significant, and a similar phenomenon was not observed in the NOAH trial. 7 Nonetheless, as a hypothesis-generating analysis, we performed separate analyses to explore

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.